This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Health Research, Inc.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Anil K Ratty: Innovator in Transgenic Mouse Research
Introduction
Anil K Ratty is a notable inventor based in Singapore, recognized for his contributions to the field of genetic research. He holds a patent for a transgenic mouse model that serves as a valuable tool for studying diseases related to dopaminergic dysfunction. His innovative work has implications for understanding and treating conditions such as Parkinsonism and schizophrenia.
Latest Patents
Anil K Ratty's patent, titled "Transgenic mouse as model for diseases involving dopaminergic dysfunction," presents a groundbreaking approach to genetic research. The invention involves a transgenic mouse exhibiting a circling phenotype due to insertional mutagenesis. This was achieved by introducing genetic material into the mouse's genome at an embryonic stage, which alters an endogenous genetic locus affecting motor function. The transgenic mouse line, designated TgX15, has been found to be a significant resource for investigating the molecular genetic mechanisms that influence brain function and behavior.
Career Highlights
Throughout his career, Anil K Ratty has worked with esteemed organizations such as Health Research, Inc. and the State University of New York. His research has contributed to advancements in understanding genetic disorders and developing potential therapeutic agents.
Collaborations
Anil K Ratty has collaborated with notable colleagues, including Stanley D Glick and Kenneth W Gross, enhancing the impact of his research through shared expertise and knowledge.
Conclusion
Anil K Ratty's innovative work in developing a transgenic mouse model has opened new avenues for research in dopaminergic dysfunction. His contributions are vital for advancing our understanding of neurological disorders and improving therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile